Show simple item record

dc.contributor.authorArca-Lafuente, Sonia 
dc.contributor.authorMartinez-Roman, Paula 
dc.contributor.authorMate-Cano, Irene 
dc.contributor.authorMadrid, Ricardo
dc.contributor.authorBriz, Verónica 
dc.date.accessioned2021-02-16T13:57:35Z
dc.date.available2021-02-16T13:57:35Z
dc.date.issued2020
dc.identifier.citationJ Infect . 2020 Jan;80(1):8-15.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/11912
dc.description.abstractHepatitis C virus (HCV) is the primary etiologic agent of liver cirrhosis or hepatocellular carcinoma. HCV elevated infection rates are mostly due to the lack of an accurate and accessible screening and diagnosis, especially in low- and middle-income countries. Conventional HCV diagnostic algorithm consists of a serological test followed by a nucleic acid test. This sequence of tests is time consuming and not affordable for low-resource settings. Nanotechnology have introduced new promising tests for the diagnose of infectious diseases. Based on the employment of nanoparticles and other nanomaterials which lead to highly sensitive and specific nanoscale tests, most of them target pathogen genome. Implementation of nanoscale tests, which are affordable, portable and easy to use by non-specialized personal, would improve HCV diagnosis algorithm. In this review, we have summed up the current emerging nanotechnology tools, which will improve actual screening and treatment programs, and help to reach HCV elimination proposal.es_ES
dc.description.sponsorshipFinancial support was provided by the Community of Madrid , call for grants for the completion of Industrial Ph.D. to VB and RM ( IND2017/BMD-7683 ).es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relation.isversionofPublisher's versiones_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectDiagnosises_ES
dc.subjectHepatitis C viruses_ES
dc.subjectNanotecnologyes_ES
dc.titleNanotechnology: A reality for diagnosis of HCV infectious disease.es_ES
dc.typeArtículoes_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.identifier.pubmedID31580870es_ES
dc.format.volume80es_ES
dc.format.number1es_ES
dc.format.page8-15es_ES
dc.identifier.doi10.1016/j.jinf.2019.09.010es_ES
dc.contributor.funderComunidad de Madrid
dc.description.peerreviewedes_ES
dc.identifier.e-issn1532-2742es_ES
dc.relation.publisherversionhttps://doi.org/10.1016/j.jinf.2019.09.010es_ES
dc.identifier.journalThe Journal of infectiones_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This item is licensed under a: Attribution-NonCommercial-NoDerivatives 4.0 Internacional